• Explore /
  • Poster
  • / Updated results of a phase Ib single-center study of pembrolizumab in combination with chemotherapy in patients with locally advanced or metastatic small cell/neuroendocrine cancers of the prostate and urothelium.

Updated results of a phase Ib single-center study of pembrolizumab in combination with chemotherapy in patients with locally advanced or metastatic small cell/neuroendocrine cancers of the prostate and urothelium.

Abstract Poster

Authors

null

Arnold I. Chin

Department of Urology, UCLA, Los Angeles, CA

Arnold I. Chin , Ann Ly , Sara Rodriguez , Ankush Sachdeva , Nazy Zomorodian , Hanwei Zhang , Jiyoon Kim , Gang Li , Matthew Rettig , Sandy Liu , Alexandra Drakaki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03582475

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 165)

DOI

10.1200/JCO.2023.41.6_suppl.165

Abstract #

165

Poster Bd #

F3

Abstract Disclosures

Similar Posters

First Author: Arnold I. Chin

First Author: Robert A. Ramirez

First Author: Amin Nassar

First Author: Evan Y. Yu